HEADER LIGASE/LIGASE INHIBITOR 13-NOV-12 4HY5 TITLE CRYSTAL STRUCTURE OF CIAP1 BIR3 BOUND TO T3256336 COMPND MOL_ID: 1; COMPND 2 MOLECULE: BACULOVIRAL IAP REPEAT-CONTAINING PROTEIN 2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BIR3; COMPND 5 SYNONYM: C-IAP1, IAP HOMOLOG B, INHIBITOR OF APOPTOSIS PROTEIN 2, COMPND 6 IAP-2, HIAP-2, HIAP2, RING FINGER PROTEIN 48, TNFR2-TRAF-SIGNALING COMPND 7 COMPLEX PROTEIN 2; COMPND 8 EC: 6.3.2.-; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: API1, BIRC2, IAP2, MIHB, RNF48; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS IAP FAMILY, BIR REPEATS, CARD DOMAIN, RING-TYPE ZINC FINGER, LIGASE- KEYWDS 2 LIGASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.R.DOUGAN,G.P.SNELL REVDAT 5 28-FEB-24 4HY5 1 REMARK SEQADV LINK REVDAT 4 09-SEP-15 4HY5 1 AUTHOR REVDAT 3 07-AUG-13 4HY5 1 HEADER HETATM REMARK REVDAT 2 27-FEB-13 4HY5 1 JRNL REVDAT 1 30-JAN-13 4HY5 0 JRNL AUTH K.HASHIMOTO,B.SAITO,N.MIYAMOTO,Y.OGURO,D.TOMITA,Z.SHIOKAWA, JRNL AUTH 2 M.ASANO,H.KAKEI,N.TAYA,M.KAWASAKI,H.SUMI,M.YABUKI,K.IWAI, JRNL AUTH 3 S.YOSHIDA,M.YOSHIMATSU,K.AOYAMA,Y.KOSUGI,T.KOJIMA, JRNL AUTH 4 N.MORISHITA,D.R.DOUGAN,G.P.SNELL,S.IMAMURA,T.ISHIKAWA JRNL TITL DESIGN AND SYNTHESIS OF POTENT INHIBITOR OF APOPTOSIS (IAP) JRNL TITL 2 PROTEINS ANTAGONISTS BEARING AN JRNL TITL 3 OCTAHYDROPYRROLO[1,2-A]PYRAZINE SCAFFOLD AS A NOVEL PROLINE JRNL TITL 4 MIMETIC. JRNL REF J.MED.CHEM. V. 56 1228 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 23298277 JRNL DOI 10.1021/JM301674Z REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.6.0117 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.2 REMARK 3 NUMBER OF REFLECTIONS : 24700 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.205 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1317 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.80 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1288 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 73.58 REMARK 3 BIN R VALUE (WORKING SET) : 0.2360 REMARK 3 BIN FREE R VALUE SET COUNT : 60 REMARK 3 BIN FREE R VALUE : 0.2560 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1512 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 88 REMARK 3 SOLVENT ATOMS : 166 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.51 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.90000 REMARK 3 B22 (A**2) : -0.98000 REMARK 3 B33 (A**2) : 1.88000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.100 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.100 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.066 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.606 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.965 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1675 ; 0.010 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 6 ; 0.621 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2271 ; 1.242 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): 10 ;26.710 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 183 ; 4.321 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 88 ;33.407 ;22.727 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 256 ;13.511 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;16.546 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 217 ; 0.086 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1315 ; 0.009 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 5 ; 0.063 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 252 A 346 REMARK 3 ORIGIN FOR THE GROUP (A): 0.4251 17.9274 26.5793 REMARK 3 T TENSOR REMARK 3 T11: 0.0300 T22: 0.0146 REMARK 3 T33: 0.0445 T12: -0.0085 REMARK 3 T13: -0.0214 T23: -0.0071 REMARK 3 L TENSOR REMARK 3 L11: 1.4727 L22: 4.0453 REMARK 3 L33: 3.0779 L12: 0.2315 REMARK 3 L13: 0.8596 L23: 2.3858 REMARK 3 S TENSOR REMARK 3 S11: -0.1092 S12: 0.0472 S13: 0.0806 REMARK 3 S21: -0.1671 S22: 0.0023 S23: 0.0753 REMARK 3 S31: -0.0329 S32: -0.0798 S33: 0.1069 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 257 B 346 REMARK 3 ORIGIN FOR THE GROUP (A): -13.0707 -6.2676 12.0859 REMARK 3 T TENSOR REMARK 3 T11: 0.0530 T22: 0.0763 REMARK 3 T33: 0.0367 T12: 0.0044 REMARK 3 T13: -0.0179 T23: -0.0481 REMARK 3 L TENSOR REMARK 3 L11: 2.0009 L22: 4.5434 REMARK 3 L33: 4.0470 L12: 0.0695 REMARK 3 L13: -0.5058 L23: 3.3632 REMARK 3 S TENSOR REMARK 3 S11: -0.0249 S12: 0.2165 S13: -0.0768 REMARK 3 S21: -0.1211 S22: -0.1468 S23: 0.1113 REMARK 3 S31: -0.3458 S32: -0.1629 S33: 0.1717 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN USED IF PRESENT IN REMARK 3 THE INPUT REMARK 4 REMARK 4 4HY5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 16-NOV-12. REMARK 100 THE DEPOSITION ID IS D_1000076066. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-10 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.976 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27152 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 3.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.78 REMARK 200 COMPLETENESS FOR SHELL (%) : 65.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.49000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.56 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2.2 M NACL 100MM TRIS, PH 8.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 295K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 15.55300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.15500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.08800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 61.15500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 15.55300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.08800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 232 REMARK 465 GLY A 233 REMARK 465 SER A 234 REMARK 465 SER A 235 REMARK 465 HIS A 236 REMARK 465 HIS A 237 REMARK 465 HIS A 238 REMARK 465 HIS A 239 REMARK 465 HIS A 240 REMARK 465 HIS A 241 REMARK 465 SER A 242 REMARK 465 SER A 243 REMARK 465 GLY A 244 REMARK 465 GLU A 245 REMARK 465 ASN A 246 REMARK 465 LEU A 247 REMARK 465 TYR A 248 REMARK 465 PHE A 249 REMARK 465 GLN A 250 REMARK 465 GLY A 251 REMARK 465 MET B 232 REMARK 465 GLY B 233 REMARK 465 SER B 234 REMARK 465 SER B 235 REMARK 465 HIS B 236 REMARK 465 HIS B 237 REMARK 465 HIS B 238 REMARK 465 HIS B 239 REMARK 465 HIS B 240 REMARK 465 HIS B 241 REMARK 465 SER B 242 REMARK 465 SER B 243 REMARK 465 GLY B 244 REMARK 465 GLU B 245 REMARK 465 ASN B 246 REMARK 465 LEU B 247 REMARK 465 TYR B 248 REMARK 465 PHE B 249 REMARK 465 GLN B 250 REMARK 465 GLY B 251 REMARK 465 GLY B 252 REMARK 465 SER B 253 REMARK 465 SER B 254 REMARK 465 ILE B 255 REMARK 465 SER B 256 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 268 NE - CZ - NH2 ANGL. DEV. = -8.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 295 -125.17 48.42 REMARK 500 ASN B 295 -123.24 51.20 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 300 SG REMARK 620 2 CYS A 303 SG 108.4 REMARK 620 3 HIS A 320 NE2 101.4 114.4 REMARK 620 4 CYS A 327 SG 114.9 109.1 108.6 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN B 401 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS B 300 SG REMARK 620 2 CYS B 303 SG 109.4 REMARK 620 3 HIS B 320 NE2 99.9 116.9 REMARK 620 4 CYS B 327 SG 114.7 108.8 107.1 REMARK 620 N 1 2 3 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE ANTAGONIST REMARK 630 MOLECULE NAME: (3S,7R,8AR)-2-{(2S)-2-(4,4-DIFLUOROCYCLOHEXYL)-2- REMARK 630 [(N-METHYL-L-ALANYL)AMINO]ACETYL}-N-[(4R)-3,4-DIHYDRO-2H-CHROMEN-4- REMARK 630 YL]-7-ETHOXYOCTAHYDROPYRROLO[1,2-A]PYRAZINE-3-CARBOXAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 1AQ A 402 REMARK 630 1AQ B 402 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: MAA 1Y2 1Y3 1XY REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1AQ A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ZN B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1AQ B 402 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HY4 RELATED DB: PDB REMARK 900 SAME PROTEIN(CIAP)COMPLEXED WITH A DIFFERENT LIGAND.(T3170284) REMARK 900 RELATED ID: 4HY0 RELATED DB: PDB REMARK 900 REALTED PROTEIN(XIAP)IN COMPLEX WITH SAME LIGAND.(T3256336) DBREF 4HY5 A 234 346 UNP Q13490 BIRC2_HUMAN 238 352 DBREF 4HY5 B 234 346 UNP Q13490 BIRC2_HUMAN 238 352 SEQADV 4HY5 MET A 232 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 GLY A 233 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 SER A 235 UNP Q13490 GLU 239 CONFLICT SEQADV 4HY5 HIS A 237 UNP Q13490 ARG 241 CONFLICT SEQADV 4HY5 HIS A 238 UNP Q13490 ARG 242 CONFLICT SEQADV 4HY5 A UNP Q13490 PHE 244 DELETION SEQADV 4HY5 A UNP Q13490 PRO 245 DELETION SEQADV 4HY5 A UNP Q13490 ASN 246 DELETION SEQADV 4HY5 A UNP Q13490 CYS 247 DELETION SEQADV 4HY5 A UNP Q13490 PRO 248 DELETION SEQADV 4HY5 A UNP Q13490 PHE 249 DELETION SEQADV 4HY5 HIS A 240 UNP Q13490 LEU 250 CONFLICT SEQADV 4HY5 HIS A 241 UNP Q13490 GLU 251 CONFLICT SEQADV 4HY5 SER A 242 UNP Q13490 ASN 252 CONFLICT SEQADV 4HY5 GLY A 244 UNP Q13490 LEU 254 CONFLICT SEQADV 4HY5 ASN A 246 UNP Q13490 THR 256 CONFLICT SEQADV 4HY5 TYR A 248 UNP Q13490 ARG 258 CONFLICT SEQADV 4HY5 GLN A 250 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 GLY A 251 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 GLY A 252 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 SER A 253 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 MET B 232 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 GLY B 233 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 SER B 235 UNP Q13490 GLU 239 CONFLICT SEQADV 4HY5 HIS B 237 UNP Q13490 ARG 241 CONFLICT SEQADV 4HY5 HIS B 238 UNP Q13490 ARG 242 CONFLICT SEQADV 4HY5 B UNP Q13490 PHE 244 DELETION SEQADV 4HY5 B UNP Q13490 PRO 245 DELETION SEQADV 4HY5 B UNP Q13490 ASN 246 DELETION SEQADV 4HY5 B UNP Q13490 CYS 247 DELETION SEQADV 4HY5 B UNP Q13490 PRO 248 DELETION SEQADV 4HY5 B UNP Q13490 PHE 249 DELETION SEQADV 4HY5 HIS B 240 UNP Q13490 LEU 250 CONFLICT SEQADV 4HY5 HIS B 241 UNP Q13490 GLU 251 CONFLICT SEQADV 4HY5 SER B 242 UNP Q13490 ASN 252 CONFLICT SEQADV 4HY5 GLY B 244 UNP Q13490 LEU 254 CONFLICT SEQADV 4HY5 ASN B 246 UNP Q13490 THR 256 CONFLICT SEQADV 4HY5 TYR B 248 UNP Q13490 ARG 258 CONFLICT SEQADV 4HY5 GLN B 250 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 GLY B 251 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 GLY B 252 UNP Q13490 EXPRESSION TAG SEQADV 4HY5 SER B 253 UNP Q13490 EXPRESSION TAG SEQRES 1 A 115 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 115 GLU ASN LEU TYR PHE GLN GLY GLY SER SER ILE SER ASN SEQRES 3 A 115 LEU SER MET GLN THR HIS ALA ALA ARG MET ARG THR PHE SEQRES 4 A 115 MET TYR TRP PRO SER SER VAL PRO VAL GLN PRO GLU GLN SEQRES 5 A 115 LEU ALA SER ALA GLY PHE TYR TYR VAL GLY ARG ASN ASP SEQRES 6 A 115 ASP VAL LYS CYS PHE CYS CYS ASP GLY GLY LEU ARG CYS SEQRES 7 A 115 TRP GLU SER GLY ASP ASP PRO TRP VAL GLU HIS ALA LYS SEQRES 8 A 115 TRP PHE PRO ARG CYS GLU PHE LEU ILE ARG MET LYS GLY SEQRES 9 A 115 GLN GLU PHE VAL ASP GLU ILE GLN GLY ARG TYR SEQRES 1 B 115 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 115 GLU ASN LEU TYR PHE GLN GLY GLY SER SER ILE SER ASN SEQRES 3 B 115 LEU SER MET GLN THR HIS ALA ALA ARG MET ARG THR PHE SEQRES 4 B 115 MET TYR TRP PRO SER SER VAL PRO VAL GLN PRO GLU GLN SEQRES 5 B 115 LEU ALA SER ALA GLY PHE TYR TYR VAL GLY ARG ASN ASP SEQRES 6 B 115 ASP VAL LYS CYS PHE CYS CYS ASP GLY GLY LEU ARG CYS SEQRES 7 B 115 TRP GLU SER GLY ASP ASP PRO TRP VAL GLU HIS ALA LYS SEQRES 8 B 115 TRP PHE PRO ARG CYS GLU PHE LEU ILE ARG MET LYS GLY SEQRES 9 B 115 GLN GLU PHE VAL ASP GLU ILE GLN GLY ARG TYR HET ZN A 401 1 HET 1AQ A 402 43 HET ZN B 401 1 HET 1AQ B 402 43 HETNAM ZN ZINC ION HETNAM 1AQ (3S,7R,8AR)-2-{(2S)-2-(4,4-DIFLUOROCYCLOHEXYL)-2-[(N- HETNAM 2 1AQ METHYL-L-ALANYL)AMINO]ACETYL}-N-[(4R)-3,4-DIHYDRO-2H- HETNAM 3 1AQ CHROMEN-4-YL]-7-ETHOXYOCTAHYDROPYRROLO[1,2-A]PYRAZINE- HETNAM 4 1AQ 3-CARBOXAMIDE FORMUL 3 ZN 2(ZN 2+) FORMUL 4 1AQ 2(C31 H45 F2 N5 O5) FORMUL 7 HOH *166(H2 O) HELIX 1 1 ASN A 257 GLN A 261 5 5 HELIX 2 2 THR A 262 THR A 269 1 8 HELIX 3 3 PHE A 270 TRP A 273 5 4 HELIX 4 4 GLN A 280 ALA A 287 1 8 HELIX 5 5 ASP A 315 PHE A 324 1 10 HELIX 6 6 CYS A 327 GLY A 335 1 9 HELIX 7 7 GLY A 335 GLY A 344 1 10 HELIX 8 8 ARG A 345 TYR A 346 5 2 HELIX 9 9 ASN B 257 GLN B 261 5 5 HELIX 10 10 THR B 262 THR B 269 1 8 HELIX 11 11 PHE B 270 TRP B 273 5 4 HELIX 12 12 GLN B 280 ALA B 287 1 8 HELIX 13 13 ASP B 315 PHE B 324 1 10 HELIX 14 14 CYS B 327 GLY B 335 1 9 HELIX 15 15 GLY B 335 GLN B 343 1 9 SHEET 1 A 3 PHE A 289 TYR A 291 0 SHEET 2 A 3 VAL A 298 CYS A 300 -1 O LYS A 299 N TYR A 290 SHEET 3 A 3 GLY A 306 LEU A 307 -1 O LEU A 307 N VAL A 298 SHEET 1 B 3 PHE B 289 TYR B 291 0 SHEET 2 B 3 VAL B 298 CYS B 300 -1 O LYS B 299 N TYR B 290 SHEET 3 B 3 GLY B 306 LEU B 307 -1 O LEU B 307 N VAL B 298 LINK SG CYS A 300 ZN ZN A 401 1555 1555 2.32 LINK SG CYS A 303 ZN ZN A 401 1555 1555 2.35 LINK NE2 HIS A 320 ZN ZN A 401 1555 1555 2.04 LINK SG CYS A 327 ZN ZN A 401 1555 1555 2.32 LINK SG CYS B 300 ZN ZN B 401 1555 1555 2.34 LINK SG CYS B 303 ZN ZN B 401 1555 1555 2.33 LINK NE2 HIS B 320 ZN ZN B 401 1555 1555 2.07 LINK SG CYS B 327 ZN ZN B 401 1555 1555 2.31 SITE 1 AC1 4 CYS A 300 CYS A 303 HIS A 320 CYS A 327 SITE 1 AC2 12 ASP A 297 GLY A 306 LEU A 307 ARG A 308 SITE 2 AC2 12 CYS A 309 GLU A 311 ASP A 314 GLU A 319 SITE 3 AC2 12 TRP A 323 HOH A 550 HOH A 553 HOH A 589 SITE 1 AC3 4 CYS B 300 CYS B 303 HIS B 320 CYS B 327 SITE 1 AC4 17 MET A 267 PHE A 270 LEU B 258 GLN B 261 SITE 2 AC4 17 THR B 262 GLY B 306 LEU B 307 ARG B 308 SITE 3 AC4 17 CYS B 309 TRP B 310 GLU B 311 ASP B 314 SITE 4 AC4 17 GLU B 319 TRP B 323 HOH B 547 HOH B 549 SITE 5 AC4 17 HOH B 560 CRYST1 31.106 68.176 122.310 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.032148 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014668 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008176 0.00000